Fulcrum Therapeutics Inc. – Filings and Transcripts

NASDAQ: FULC
Share price (7/22/26): $3.70
Market cap (7/22/26): $246 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Free writing prospectus

Prospectus supplement for primary offering

Registration of securities for employees

Ownership Filter

Tang Kevin, Tang Capital Management LLC

BlackRock Portfolio Management LLC

Tang Capital Management LLC

Tang Kevin, Tang Capital Management LLC

Tang Kevin, Tang Capital Management LLC

News Filter

Shareholder Vote Results

Change in Directors, Officers or Compensation

Cost of Exit or Disposal Activities, Other Events

Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review

Announces Recent Business Highlights and Financial Results for First Quarter 2026

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Scanned paper annual report submission